XML 71 R5.htm IDEA: XBRL DOCUMENT  v2.3.0.11
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands
12 Months Ended
Mar. 31, 2011
Mar. 31, 2010
Mar. 31, 2009
Cash flows from operating activities:      
Net income $ 418,950 $ 217,005 $ 245,587
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 106,612 90,057 96,046
Deferred income taxes 24,003 22,330 28,111
Share-based compensation expense related to equity incentive plans 36,812 36,778 32,481
Excess tax benefit from share-based compensation (1,854) (2,094) (6,798)
Convertible debt derivatives - revaluation and amortization (185) 230 (944)
Amortization of junior convertible debenture issuance costs 219 215 215
Amortization of debt discount on convertible debentures 6,847 6,258 5,171
Gains on equity method investments (157) 0 0
Gain on sale of assets (89) (100) (100)
Unrealized impairment loss on available-for-sale investments 4,659 4,750 3,560
Special charges 0 1,238 860
Sales (purchases) of trading securities, net 0 86,970 (73,510)
(Gain) loss on trading securities 0 (7,425) 6,332
Changes in operating assets and liabilities:      
Decrease (increase) in accounts receivable 6,341 (49,078) 50,832
(Increase) decrease in inventories (22,068) 15,239 (4,110)
Increase (decrease) in deferred income on shipments to distributors 38,781 15,010 (11,510)
(Decrease) increase in accounts payable and accrued liabilities (638) 29,583 (25,097)
Change in other assets and liabilities (35,572) (14,919) (38,473)
Cash flows from investing activities:      
Purchases of available-for-sale investments (1,008,056) (1,576,044) (2,479,175)
Sales and maturities of available-for-sale investments 1,055,286 1,502,127 2,583,152
Purchase of Silicon Storage Technology, Inc, net of cash received (112,707) 0 0
Investment in Silicon Storage Technology, Inc. 0 (58,402) 0
Investment in other assets (29,587) (15,439) (21,600)
Proceeds from sale of assets 31,668 100 166
Capital expenditures (124,454) (47,604) (102,370)
Net cash (used in) provided by investing activities (187,850) (195,262) (19,827)
Cash flows from financing activities:      
Payment of cash dividend (256,811) (249,556) (246,657)
Repurchase of common stock 0 0 (123,929)
Proceeds from sale of common stock 71,940 36,478 33,555
Excess tax benefit from share-based compensation 1,854 2,094 6,798
Net cash used in financing activities (183,017) (210,984) (330,233)
Net increase (decrease) in cash and cash equivalents 211,794 45,801 (41,407)
Cash and cash equivalents at beginning of year 492,130 446,329 487,736
Cash and cash equivalents at end of year $ 703,924 $ 492,130 $ 446,329